GOLDMAN SACHS GROUP INC

Position in SPRO — Spero Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in SPRO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$567,936

+$457,060 QoQ

Shares Held

256,985

+363.6% QoQ

Ownership

0.441%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#15

of 59 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. SPRO ranks #281 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$567,936	256,985	+363.6%	Shares	Defined	2026-08-14
2022-09-30	$110,876	55,438	-81.7%	Shares	Defined	2024-05-14
2022-06-30	$224,671	303,201	+114.4%	Shares	Defined	2024-05-14
2022-03-31	$1,230,405	141,426	+2.0%	Shares	Defined	2022-05-16
2021-12-31	$2,219,161	138,611	+0.8%	Shares	Defined	2022-02-17
2021-09-30	$2,532,828	137,579	+1.0%	Shares	Defined	2022-01-20
2021-06-30	$1,902,216	136,262	-46.7%	Shares	Defined	2021-08-13
2021-03-31	$3,765,375	255,800	+514.6%	Shares	Defined	2021-05-17
2020-12-31	$807,030	41,621	+32.7%	Shares	Defined	2021-02-12
2020-09-30	$350,033	31,365	-39.6%	Shares	Defined	2020-11-13
2020-06-30	$702,991	51,958	+90.6%	Shares	Defined	2020-08-12
2020-03-31	$220,276	27,262	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.